Literature DB >> 20083733

Endothelial-regenerating cells: an expanding universe.

Martin Steinmetz1, Georg Nickenig, Nikos Werner.   

Abstract

Atherosclerosis is the most common cause for cardiovascular diseases and is based on endothelial dysfunction. A growing body of evidence suggests the contribution of bone marrow-derived endothelial progenitor cells, monocytic cells, and mature endothelial cells to vessel formation and endothelial rejuvenation. To this day, various subsets of these endothelial-regenerating cells have been identified according to cellular origin, phenotype, and properties in vivo and in vitro. However, the definition and biology, especially of endothelial progenitor cells, is complex and under heavy debate. In this review, we focus on current definitions of endothelial progenitor cells, highlight the clinical relevance of endothelial-regenerating cells, and provide new insights into cell-cell interactions involved in endothelial cell rejuvenation.

Entities:  

Mesh:

Year:  2010        PMID: 20083733     DOI: 10.1161/HYPERTENSIONAHA.109.134213

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  33 in total

1.  The isolation and culture of endothelial colony-forming cells from human and rat lungs.

Authors:  Rajesh S Alphonse; Arul Vadivel; Shumei Zhong; Shumei Zong; Suzanne McConaghy; Robin Ohls; Mervin C Yoder; Bernard Thébaud
Journal:  Nat Protoc       Date:  2015-10-08       Impact factor: 13.491

Review 2.  Telomeres, atherosclerosis, and the hemothelium: the longer view.

Authors:  Abraham Aviv; Daniel Levy
Journal:  Annu Rev Med       Date:  2011-10-17       Impact factor: 13.739

3.  Decreased endothelial progenitor cells in preeclampsia and consequences for developmental programming.

Authors:  Kara M Beasley; Andrew T Lovering; Jeffrey S Gilbert
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

Review 4.  Endothelial progenitor cells: quo vadis?

Authors:  Matthew R Richardson; Mervin C Yoder
Journal:  J Mol Cell Cardiol       Date:  2010-07-29       Impact factor: 5.000

5.  Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8.

Authors:  Reinhold J Medina; Christina L O'Neill; T Michelle O'Doherty; Henry Knott; Jasenka Guduric-Fuchs; Tom A Gardiner; Alan W Stitt
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

6.  Apolipoprotein A-I mimetic peptide D-4F promotes human endothelial progenitor cell proliferation, migration, adhesion though eNOS/NO pathway.

Authors:  Zhengang Zhang; Jianhua Qun; Chunmei Cao; Jun Wang; Wei Li; Yong Wu; Lin Du; Pei Zhao; Kaizheng Gong
Journal:  Mol Biol Rep       Date:  2011-09-25       Impact factor: 2.316

7.  Effects of Quantum Dot Labeling on Endothelial Progenitor Cell Function and Viability.

Authors:  Matyas Molnar; Peter Friberg; Ying Fu; Mikeal Brisslert; Michael Adams; Yun Chen
Journal:  Cell Med       Date:  2010-11-05

8.  Iptakalim ameliorates hypoxia-impaired human endothelial colony-forming cells proliferation, migration, and angiogenesis via Akt/eNOS pathways.

Authors:  Mengyu He; Ting Cui; Qing Cai; Hong Wang; Hui Kong; Weiping Xie
Journal:  Pulm Circ       Date:  2019-10-18       Impact factor: 3.017

9.  Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement.

Authors:  G Mandraffino; E Imbalzano; M A Sardo; A D'Ascola; F Mamone; A Lo Gullo; A Alibrandi; S Loddo; E Mormina; A David; A Saitta
Journal:  J Hum Hypertens       Date:  2014-02-20       Impact factor: 3.012

10.  PPARalpha is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis.

Authors:  Tarek Benameur; Simon Tual-Chalot; Ramaroson Andriantsitohaina; María Carmen Martínez
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.